{
  "disease_name": "Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency",
  "orpha_code": "5",
  "drugs": [
    {
      "name": "Triheptanoin",
      "substance_url": "/en/drug/substance/317333?name=5&mode=orpha&region=&status=all",
      "substance_id": "317333",
      "regulatory_url": "/en/drug/regulatory/444892?name=5&mode=orpha&region=",
      "regulatory_id": "444892",
      "orpha_substance_code": "ORPHA:5",
      "details": [
        "Triheptanoin(Medicinal product                        - 28/07/2015)Disease(s) concernedORPHA:5 Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency",
        "Triheptanoin(Medicinal product                        - 28/07/2015)",
        "(Medicinal product                        - 28/07/2015)",
        "Disease(s) concernedORPHA:5 Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/317333?name=5&mode=orpha&region=&status=all",
          "text": "Triheptanoin",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/5",
          "text": "ORPHA:5 Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/444892?name=5&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Sodium (4-{(E)-3-(4-fluorophenyl)-3-[4-(3-morpholin-4-yl-prop1ynyl)phenyl]allyloxy}-2-methylphenoxy)acetate",
      "substance_url": "/en/drug/substance/604812?name=5&mode=orpha&region=&status=all",
      "substance_id": "604812",
      "regulatory_url": "/en/drug/regulatory/604835?name=5&mode=orpha&region=",
      "regulatory_id": "604835",
      "orpha_substance_code": "ORPHA:5",
      "details": [
        "Sodium (4-{(E)-3-(4-fluorophenyl)-3-[4-(3-morpholin-4-yl-prop1ynyl)phenyl]allyloxy}-2-methylphenoxy)acetate(Medicinal product                        - 21/08/2020)Disease(s) concernedORPHA:5 Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency",
        "Sodium (4-{(E)-3-(4-fluorophenyl)-3-[4-(3-morpholin-4-yl-prop1ynyl)phenyl]allyloxy}-2-methylphenoxy)acetate(Medicinal product                        - 21/08/2020)",
        "(Medicinal product                        - 21/08/2020)",
        "Disease(s) concernedORPHA:5 Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/604812?name=5&mode=orpha&region=&status=all",
          "text": "Sodium (4-{(E)-3-(4-fluorophenyl)-3-[4-(3-morpholin-4-yl-prop1ynyl)phenyl]allyloxy}-2-methylphenoxy)acetate",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/5",
          "text": "ORPHA:5 Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/604835?name=5&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Triheptanoin",
      "substance_url": "/en/drug/substance/317333?name=5&mode=orpha&region=&status=all",
      "substance_id": "317333",
      "regulatory_url": "/en/drug/regulatory/324201?name=5&mode=orpha&region=",
      "regulatory_id": "324201",
      "orpha_substance_code": "ORPHA:5",
      "details": [
        "Triheptanoin(Medicinal product                        - 06/12/2012)Disease(s) concernedORPHA:5 Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency",
        "Triheptanoin(Medicinal product                        - 06/12/2012)",
        "(Medicinal product                        - 06/12/2012)",
        "Disease(s) concernedORPHA:5 Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/317333?name=5&mode=orpha&region=&status=all",
          "text": "Triheptanoin",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/5",
          "text": "ORPHA:5 Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/324201?name=5&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "DOJOLVI",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/623538?name=5&mode=orpha&region=",
      "regulatory_id": "623538",
      "orpha_substance_code": "ORPHA:26793",
      "details": [
        "DOJOLVI(Tradename                        - 30/06/2020)Disease(s) concernedORPHA:157 Carnitine palmitoyltransferase II deficiencyORPHA:156 Carnitine palmitoyl transferase 1A deficiencyORPHA:746 Mitochondrial trifunctional protein deficiencyORPHA:5 Long chain 3-hydroxyacyl-CoA dehydrogenase deficiencyORPHA:26793 Very long chain acyl-CoA dehydrogenase deficiency",
        "DOJOLVI(Tradename                        - 30/06/2020)",
        "(Tradename                        - 30/06/2020)",
        "Disease(s) concernedORPHA:157 Carnitine palmitoyltransferase II deficiencyORPHA:156 Carnitine palmitoyl transferase 1A deficiencyORPHA:746 Mitochondrial trifunctional protein deficiencyORPHA:5 Long chain 3-hydroxyacyl-CoA dehydrogenase deficiencyORPHA:26793 Very long chain acyl-CoA dehydrogenase deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/615857?name=5&mode=orpha&region=&status=all",
          "text": "DOJOLVI",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/157",
          "text": "ORPHA:157 Carnitine palmitoyltransferase II deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/156",
          "text": "ORPHA:156 Carnitine palmitoyl transferase 1A deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/746",
          "text": "ORPHA:746 Mitochondrial trifunctional protein deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/5",
          "text": "ORPHA:5 Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/26793",
          "text": "ORPHA:26793 Very long chain acyl-CoA dehydrogenase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/623538?name=5&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Encaleret sulfate",
      "substance_url": "/en/drug/substance/627727?name=5&mode=orpha&region=&status=all",
      "substance_id": "627727",
      "regulatory_url": "/en/drug/regulatory/627728?name=5&mode=orpha&region=",
      "regulatory_id": "627728",
      "orpha_substance_code": "ORPHA:208593",
      "details": [
        "Encaleret sulfate(Medicinal product                        - 15/10/2021)Disease(s) concernedORPHA:181405 Rare hypoparathyroidismORPHA:208593 Genetic hypoparathyroidism",
        "Encaleret sulfate(Medicinal product                        - 15/10/2021)",
        "(Medicinal product                        - 15/10/2021)",
        "Disease(s) concernedORPHA:181405 Rare hypoparathyroidismORPHA:208593 Genetic hypoparathyroidism",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/627727?name=5&mode=orpha&region=&status=all",
          "text": "Encaleret sulfate",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/181405",
          "text": "ORPHA:181405 Rare hypoparathyroidism",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/208593",
          "text": "ORPHA:208593 Genetic hypoparathyroidism",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/627728?name=5&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Palopegteriparatide",
      "substance_url": "/en/drug/substance/604906?name=5&mode=orpha&region=&status=all",
      "substance_id": "604906",
      "regulatory_url": "/en/drug/regulatory/604907?name=5&mode=orpha&region=",
      "regulatory_id": "604907",
      "orpha_substance_code": "ORPHA:208593",
      "details": [
        "Palopegteriparatide(Medicinal product                        - 19/10/2020)Disease(s) concernedORPHA:2238 Familial isolated hypoparathyroidismORPHA:181405 Rare hypoparathyroidismORPHA:208593 Genetic hypoparathyroidism",
        "Palopegteriparatide(Medicinal product                        - 19/10/2020)",
        "(Medicinal product                        - 19/10/2020)",
        "Disease(s) concernedORPHA:2238 Familial isolated hypoparathyroidismORPHA:181405 Rare hypoparathyroidismORPHA:208593 Genetic hypoparathyroidism",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/604906?name=5&mode=orpha&region=&status=all",
          "text": "Palopegteriparatide",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/2238",
          "text": "ORPHA:2238 Familial isolated hypoparathyroidism",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/181405",
          "text": "ORPHA:181405 Rare hypoparathyroidism",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/208593",
          "text": "ORPHA:208593 Genetic hypoparathyroidism",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/604907?name=5&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Recombinant human parathyroid hormone",
      "substance_url": "/en/drug/substance/367963?name=5&mode=orpha&region=&status=all",
      "substance_id": "367963",
      "regulatory_url": "/en/drug/regulatory/377573?name=5&mode=orpha&region=",
      "regulatory_id": "377573",
      "orpha_substance_code": "ORPHA:181402",
      "details": [
        "Recombinant human parathyroid hormone(Medicinal product                        - 16/01/2014)Disease(s) concernedORPHA:2238 Familial isolated hypoparathyroidismORPHA:3453 Autoimmune polyendocrinopathy type 1ORPHA:181402 Syndrome with hypoparathyroidism",
        "Recombinant human parathyroid hormone(Medicinal product                        - 16/01/2014)",
        "(Medicinal product                        - 16/01/2014)",
        "Disease(s) concernedORPHA:2238 Familial isolated hypoparathyroidismORPHA:3453 Autoimmune polyendocrinopathy type 1ORPHA:181402 Syndrome with hypoparathyroidism",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/367963?name=5&mode=orpha&region=&status=all",
          "text": "Recombinant human parathyroid hormone",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/2238",
          "text": "ORPHA:2238 Familial isolated hypoparathyroidism",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/3453",
          "text": "ORPHA:3453 Autoimmune polyendocrinopathy type 1",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/181402",
          "text": "ORPHA:181402 Syndrome with hypoparathyroidism",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/377573?name=5&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "with hypoparathyroidism\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Burixafor",
      "substance_url": "/en/drug/substance/689505?name=5&mode=orpha&region=&status=all",
      "substance_id": "689505",
      "regulatory_url": "/en/drug/regulatory/689915?name=5&mode=orpha&region=",
      "regulatory_id": "689915",
      "orpha_substance_code": "ORPHA:565779",
      "details": [
        "Burixafor(Medicinal product                        - 22/10/2024)Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "Burixafor(Medicinal product                        - 22/10/2024)",
        "(Medicinal product                        - 22/10/2024)",
        "Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/689505?name=5&mode=orpha&region=&status=all",
          "text": "Burixafor",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565779",
          "text": "ORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/689915?name=5&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for transplant or complication after transplantation\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Treosulfan",
      "substance_url": "/en/drug/substance/90799?name=5&mode=orpha&region=&status=all",
      "substance_id": "90799",
      "regulatory_url": "/en/drug/regulatory/136690?name=5&mode=orpha&region=",
      "regulatory_id": "136690",
      "orpha_substance_code": "ORPHA:565779",
      "details": [
        "Treosulfan(Medicinal product                        - 08/04/2015)Disease(s) concernedORPHA:213500 Rare ovarian cancerORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "Treosulfan(Medicinal product                        - 08/04/2015)",
        "(Medicinal product                        - 08/04/2015)",
        "Disease(s) concernedORPHA:213500 Rare ovarian cancerORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/90799?name=5&mode=orpha&region=&status=all",
          "text": "Treosulfan",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/213500",
          "text": "ORPHA:213500 Rare ovarian cancer",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565779",
          "text": "ORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/136690?name=5&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for transplant or complication after transplantation\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "busulfan",
      "substance_url": "/en/drug/substance/46335?name=5&mode=orpha&region=&status=all",
      "substance_id": "46335",
      "regulatory_url": "/en/drug/regulatory/131973?name=5&mode=orpha&region=",
      "regulatory_id": "131973",
      "orpha_substance_code": "ORPHA:565779",
      "details": [
        "busulfan(Medicinal product                        - 21/04/1994)Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "busulfan(Medicinal product                        - 21/04/1994)",
        "(Medicinal product                        - 21/04/1994)",
        "Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/46335?name=5&mode=orpha&region=&status=all",
          "text": "busulfan",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565779",
          "text": "ORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/131973?name=5&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for transplant or complication after transplantation\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    }
  ],
  "processing_timestamp": "2025-07-07T06:03:27.933468",
  "run_number": 1,
  "total_drugs_found": 10,
  "search_url": "https://www.orpha.net/en/drug?diseaseName=Long+chain+3-hydroxyacyl-CoA+dehydrogenase+deficiency&orphaCode=5&name=5&region=&mode=orpha&status=all",
  "search_params": {
    "diseaseName": "Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency",
    "orphaCode": "5",
    "name": "5",
    "region": "",
    "mode": "orpha",
    "status": "all"
  }
}